title: Oxidative LDL modification is increased in vascular dementia and is inversely associated with cognitive performance.
abstract: It is not known whether the association between increased plasma homocysteine (Hcy) associated with LDL modification and propensity for LDL uptake by macrophages in cardiovascular disease patients holds true in vascular dementia (VaD). Plasma from 83 subjects diagnosed with Alzheimer's disease (AD), VaD, mild cognitive impairment (MCI) and from controls was analysed to examine (1) whether LDL isolated from the plasma of VaD is biochemically and functionally distinct from that isolated from AD, MCI or controls; and (2) whether such biomarkers of LDL phenotype are related to plasma folate levels, Hcy levels and/or to disease severity. Folate and vitamin B6 levels were significantly lower in VaD subjects than in controls. VaD-LDL showed increased protein carbonyl content (p < 0.05) and was more susceptible to scavenging by macrophages (p < 0.05) than AD- or control-LDL. Patients from the VaD cohort were more prevalent in the lowest tertile for HDL:LDL and the upper tertile for LDL oxidation; the combined parameters of HDL cholesterol, LDL oxidation and scavenging by macrophages show 87% sensitivity towards VaD detection. The association between folate deficiency, LDL modification and dysfunction in VaD but not in AD may provide a novel biomarker assessment to discriminate between the diseases.
authors.affiliation: School of Life and Health Sciences, Aston University, Birmingham, UK.
authors.forename: L
authors.initials: L
authors.lastname: Li
authors.forename: R S
authors.initials: RS
authors.lastname: Willets
authors.forename: M C
authors.initials: MC
authors.lastname: Polidori
authors.forename: W
authors.initials: W
authors.lastname: Stahl
authors.forename: G
authors.initials: G
authors.lastname: Nelles
authors.forename: H
authors.initials: H
authors.lastname: Sies
authors.forename: H R
authors.initials: HR
authors.lastname: Griffiths
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000544:Alzheimer Disease / Q000378:metabolism; D015415:Biomarkers / Q000097:blood*; D008076:Cholesterol, HDL / Q000378:metabolism; D008078:Cholesterol, LDL / Q000378:metabolism*; D003072:Cognition Disorders / Q000209:etiology / Q000378:metabolism*; D015140:Dementia, Vascular / Q000150:complications / Q000378:metabolism*; D005260:Female; D005492:Folic Acid / Q000097:blood; D006710:Homocysteine / Q000097:blood; D006801:Humans; D008297:Male; D010084:Oxidation-Reduction
chemical_list: D015415:Biomarkers; D008076:Cholesterol, HDL; D008078:Cholesterol, LDL; D006710:Homocysteine; D005492:Folic Acid